1. Limits of [18F]-FLT PET as a biomarker of proliferation in oncology. McKinley ET, Ayers GD, Smith RA, Saleh SA, Zhao P, Washington MK, Coffey RJ, Manning HC (2013) PLoS One 8(3): e58938
    › Primary publication · 23554961 (PubMed) · PMC3598948 (PubMed Central)
  2. Helicobacter pylori promotes the expression of Krüppel-like factor 5, a mediator of carcinogenesis, in vitro and in vivo. Noto JM, Khizanishvili T, Chaturvedi R, Piazuelo MB, Romero-Gallo J, Delgado AG, Khurana SS, Sierra JC, Krishna US, Suarez G, Powell AE, Goldenring JR, Coffey RJ, Yang VW, Correa P, Mills JC, Wilson KT, Peek RM (2013) PLoS One 8(1): e54344
    › Primary publication · 23372710 (PubMed) · PMC3553174 (PubMed Central)
  3. Global phosphotyrosine proteomics identifies PKCδ as a marker of responsiveness to Src inhibition in colorectal cancer. McKinley ET, Liu H, McDonald WH, Luo W, Zhao P, Coffey RJ, Hanks SK, Manning HC (2013) PLoS One 8(11): e80207
    › Primary publication · 24260357 (PubMed) · PMC3832668 (PubMed Central)
  4. Extracellular vesicles: communication, coercion, and conditioning. Shifrin DA, Demory Beckler M, Coffey RJ, Tyska MJ (2013) Mol Biol Cell 24(9): 1253-9
    › Primary publication · 23630232 (PubMed) · PMC3639038 (PubMed Central)
  5. Deciphering genomic alterations in colorectal cancer through transcriptional subtype-based network analysis. Zhu J, Wang J, Shi Z, Franklin JL, Deane NG, Coffey RJ, Beauchamp RD, Zhang B (2013) PLoS One 8(11): e79282
    › Primary publication · 24260186 (PubMed) · PMC3829853 (PubMed Central)
  6. 3'-Deoxy-3'-18F-fluorothymidine PET predicts response to (V600E)BRAF-targeted therapy in preclinical models of colorectal cancer. McKinley ET, Smith RA, Zhao P, Fu A, Saleh SA, Uddin MI, Washington MK, Coffey RJ, Manning HC (2013) J Nucl Med 54(3): 424-30
    › Primary publication · 23341544 (PubMed) · PMC3633462 (PubMed Central)
  7. The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Powell AE, Wang Y, Li Y, Poulin EJ, Means AL, Washington MK, Higginbotham JN, Juchheim A, Prasad N, Levy SE, Guo Y, Shyr Y, Aronow BJ, Haigis KM, Franklin JL, Coffey RJ (2012) Cell 149(1): 146-58
    › Primary publication · 22464327 (PubMed) · PMC3563328 (PubMed Central)
  8. Spasmolytic polypeptide-expressing metaplasia (SPEM) in the gastric oxyntic mucosa does not arise from Lgr5-expressing cells. Nam KT, O'Neal RL, Coffey RJ, Finke PE, Barker N, Goldenring JR (2012) Gut 61(12): 1678-85
    › Primary publication · 22198711 (PubMed) · PMC3767919 (PubMed Central)
  9. Proteomic consequences of a single gene mutation in a colorectal cancer model. Halvey PJ, Zhang B, Coffey RJ, Liebler DC, Slebos RJ (2012) J Proteome Res 11(2): 1184-95
    › Primary publication · 22103262 (PubMed) · PMC3271737 (PubMed Central)
  10. Protein expression signatures for inhibition of epidermal growth factor receptor-mediated signaling. Myers MV, Manning HC, Coffey RJ, Liebler DC (2012) Mol Cell Proteomics 11(2): M111.015222
    › Primary publication · 22147731 (PubMed) · PMC3277773 (PubMed Central)